`Filed: May 14, 2015
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`COALITION FOR AFFORDABLE DRUGS VI LLC
`Petitioner,
`
`v.
`
`CELGENE CORPORATION
`Patent Owner
`
`________________
`
`Case IPR2015-01102
`Patent 6,315,720
`________________
`
`MANDATORY NOTICES BY CELGENE CORPORATION
`UNDER 35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`
`
`
`
`
`
`Case IPR2015-01102
`Patent 6,315,720
`Patent Owner Mandatory Notices
`
`
`REAL PARTY-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Celgene Corporation (“Celgene”) is the real party-in-interest. Celgene is a
`
`corporation organized and existing under the laws of the State of Delaware, having
`
`a principal place of business at 86 Morris Avenue, Summit, New Jersey 07901.
`
`Celgene owns by assignment the entire right, title, and interest in U.S. Patent No.
`
`6,315,720 (the “’720 patent”) by virtue of an Assignment of rights from the
`
`inventors, Bruce A. Williams and Joseph K. Kaminski. The Assignment was
`
`recorded with the United States Patent and Trademark Office on January 5, 2001,
`
`at Reel 11469, Frame 882.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’720 patent
`
`is the subject of two, currently-pending litigations: Celgene Corporation et al. v.
`
`Lannett Holdings, Inc. et al., 2:15-cv-697 (D.N.J.); and Celgene Corporation v.
`
`Natco Pharma Limited et al., 2:10-cv-5197 (D.N.J.). The litigation over the ’720
`
`patent in Celgene Corp. v. Natco Pharma Ltd. et al. was stayed prior to the
`
`Petitioner filing the present IPR Petition. One other litigation, Celgene
`
`Corporation v. Natco Pharma Limited et al., 2:14-cv-3126 (D.N.J.), concerns a
`
`patent related to the ’720 patent.
`
`
`
`
`
`Case IPR2015-01102
`Patent 6,315,720
`Patent Owner Mandatory Notices
`
`
`Additionally, concurrently with the present petition, Petitioner filed two
`
`additional petitions for inter parties review of the ’720 patent: IPR2015-01096
`
`and IPR2015-01103.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: nickcerrito@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`Anthony M. Insogna (Reg. No. 35,203)
`
`Contact Information:
`
`Jones Day
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`12265 El Camino Real
`
`Suite 200
`
`San Diego, CA 92130
`
`Email: aminsogna@jonesday.com
`
`Telephone: 858-314-1200
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01102
`Patent 6,315,720
`Patent Owner Mandatory Notices
`
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`
`Respectfully submitted,
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Anthony M. Insogna
`Reg. No. 35,203
`JONES DAY
`12265 El Camino Real
`Suite 200
`San Diego, CA 92130
`General Tel: (858) 314-1200
`Direct Tel: (858) 314-1130
`Fax: (858) 314-1150
`jvbiernacki@jonesday.com
`
`Attorneys for Celgene Corporation
`
`
`
`Date: May 14, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`COALITION FOR AFFORDABLE DRUGS VI LLC
`Petitioner,
`
`v.
`
`CELGENE CORPORATION
`Patent Owner
`
`________________
`
`Case IPR2015-01102
`Patent 6,315,720
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`MANDATORY NOTICES BY CELGENE CORPORATION and the attached
`
`POWER OF ATTORNEY and 3.73(b) STATEMENT were served on May 14,
`
`2015 by filing these documents through the Patent Review Processing System, as
`
`well as e-mailing copies to sarah.spires@skiermontpuckett.com,
`
`ki.o@skiermontpuckett.com, parvathi.kota@skiermontpuckett.com, and
`
`paul.skiermont@skiermontpuckett.com.
`
`Date: May 14, 2015
`
`
`
` Respectfully submitted,
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Anthony M. Insogna
`Reg. No. 35,203
`JONES DAY
`12265 El Camino Real
`Suite 200
`San Diego, CA 92130
`General Tel: (858) 314-1200
`Direct Tel: (858) 314-1130
`Fax: (858) 314-1150
`jvbiernacki@jonesday.com
`Attorneys for Celgene Corporation
`
`